Chuck Abraham, CEO

Chuck was recruited to manage the commercial launch of the product after the company’s successful completion of European and U.S. clinical trials, CE Mark and FDA Registration.

Most recently Chuck led OraMetrix, Inc. to a successful commercialization of its products and services with a cloud-based business model providing custom Orthodontic appliances to doctors for use in patients. Chuck’s additional experience includes commercialization of medical products and services.

Prior positions include leadership roles with OraMetrix, Inc., eMerge Interactive, Nellcor Puritan Bennet, and General Electric Medical Systems.

Chuck attended Mississippi State University and received a Bachelor of Science in Biological/Biosystems Engineering.

Jay Widdig, CFO

Jay is responsible for Sebacia’s financial and administration functions, specifically as it relates to the commercial launch of Sebacia’s products.

Before joining Sebacia, Jay served as vice president, chief financial officer, treasurer and corporate secretary of OraMetrix, Inc., from 2002 to 2020, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care. OraMetrix was acquired by Dentsply Sirona, Inc. in 2018. Before then, Jay was the CFO of Intrusion Inc., a publicly traded network security company and at one point he also held various managerial positions at Cyrix Corporation, a semiconductor company. Cyrix Corporation was acquired by National Semiconductor in 1997. Jay also had the opportunity to serve at Texas Instruments and Halliburton Company in various financial roles.

Jay holds a Master of Business Administration degree from Oklahoma City University and a Bachelor of Science degree in accounting from Cameron University.

Cory Anderson, VP, Clinical Marketing and Business Development

Cory is responsible for business development, European post approval studies, and commercial launch activities in Europe for the Sebacia Acne Treatment. Since starting with The Innovation Factory (TIF) over 10 years ago, he has worked in a variety of roles in TIF and TIF’s portfolio companies. These positions include his current role with Sebacia, VP of Business Development for TIF, and Program Manager for both AqueSys and NeoVista. Additionally, Cory is a Principal at Accuitive Medical Ventures. He currently serves as an observer on the MyoScience board and formerly served as an observer on the Aquesys board (acquired by Allergan).

Cory earned his MBA from Emory University and both his Bachelor and Master degrees in Biomedical Engineering from Tulane University.

In his spare time, Cory enjoys spending time with his two young children, playing tennis, and experimenting with different dishes in the kitchen.

Richard Blomgren, Director, Quality

Richard has been the guiding force for Sebacia Quality and Manufacturing, as part of The Innovation Factory (TIF) management team. In his role as Director of Quality Systems for TIF for the past 12 years, Richard brings more than 20 years expertise in quality, manufacturing, and product development. During his time at TIF, Richard has created and managed quality systems for 10 medical startup companies and helped to successfully transition 7 of these companies out of TIF.

Prior to joining TIF, Richard held quality management and quality engineering positions at Teleflex Medical (formerly Rüsch), MMG Healthcare, GEC Marconi Avionics, and Rockwell International.

Away from work, Richard enjoys hiking and camping with his four sons and volunteers as an Assistant Scoutmaster for their local Boy Scout troop.

Pedro Medrano, VP, Engineering & Program Management

Pedro recently joined Sebacia to lead engineering and commercialization readiness projects. After earning a B.S. Degree in Materials Science & Engineering, he spent time researching high-energy density capacitors for use in numerous applications, including Implantable Defibrillators. During his 15 years at St. Jude Medical, Inc., Pedro led numerous global, cross-functional teams in the development of Class III implantable devices and systems.

Prior to joining Sebacia, Pedro was the Director of the Project Management Office for Philips’ Nuclear Medicine/Imaging business, where he was responsible for New Product Development and Sustaining programs. He has also held Business Development positions with Novartis’ Eyecare Division (CIBAVISION/Alcon) and The Innovation Factory, where he performed due diligence on refractive laser surgery, Intraocular and Contact Lenses, and drug delivery devices.

In his spare time, Pedro enjoys participating in and watching all types of sports with his 3 boys.